Millennium Pharmacon International (SDPC) — Capital Reinvestment Ratio
Latest as of March 2025:
0.02x
Millennium Pharmacon International (SDPC) has a Capital Reinvestment Ratio of 0.02x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rp70.29 Billion) in capital expenditures (Rp1.09 Billion). See SDPC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
Rp70.29 Billion
IDR
Capital Expenditures
Rp1.09 Billion
IDR
Data as of
Mar 2025
Most recent filing
Millennium Pharmacon International Capital Reinvestment Ratio (2004–2022)
This chart tracks Millennium Pharmacon International's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Millennium Pharmacon International (2004–2022)
Year-by-year Capital Reinvestment Ratio for Millennium Pharmacon International from 2004 to 2022. For live market cap and broader valuation context, see SDPC market cap.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.36x | Rp41.00 Billion | Rp14.68 Billion | ▲ +573.3% |
| 2020 | 0.05x | Rp71.69 Billion | Rp3.81 Billion | ▼ -96.0% |
| 2018 | 1.35x | Rp4.72 Billion | Rp6.35 Billion | ▼ -9.3% |
| 2017 | 1.48x | Rp4.46 Billion | Rp6.61 Billion | ▲ +160.6% |
| 2012 | 0.57x | Rp2.19 Billion | Rp1.25 Billion | ▼ -21.3% |
| 2007 | 0.72x | Rp4.57 Billion | Rp3.31 Billion | ▼ -26.7% |
| 2006 | 0.99x | Rp802.62 Million | Rp792.17 Million | ▲ +59.7% |
| 2004 | 0.62x | Rp2.72 Billion | Rp1.68 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow